Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease-Reference-Cited by-全球学者库

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Published:2011-04-22 Issue:3 Volume:7 Page:280-292
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sperling Reisa A.¹,Aisen Paul S.²,Beckett Laurel A.³,Bennett David A.⁴,Craft Suzanne⁵,Fagan Anne M.⁶,Iwatsubo Takeshi⁷,Jack Clifford R.⁸,Kaye Jeffrey⁹,Montine Thomas J.¹⁰,Park Denise C.¹¹,Reiman Eric M.¹²,Rowe Christopher C.¹³,Siemers Eric¹⁴,Stern Yaakov¹⁵,Yaffe Kristine¹⁶,Carrillo Maria C.¹⁷,Thies Bill¹⁷,Morrison‐Bogorad Marcelle¹⁸,Wagster Molly V.¹⁸,Phelps Creighton H.¹⁸

Affiliation:

1. Department of NeurologyCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical SchoolBostonMAUSA

2. Department of NeurosciencesUniversity of California San DiegoSan DiegoCAUSA

3. Division of BiostatisticsSchool of Medicine, University of CaliforniaDavisCAUSA

4. Rush Alzheimer's Disease Center, Rush University Medical CenterChicagoILUSA

5. Department of Psychiatry and Behavioral SciencesGeriatric Research, Education, and Clinical Center, Veterans Affairs Puget Sound; University of Washington School of MedicineSeattleWAUSA

6. Department of NeurologyWashington University School of MedicineSt. LouisMOUSA

7. Department of NeuropathologyGraduate School of Medicine, University of TokyoTokyoJapan

8. Department of RadiologyMayo Clinic MinnesotaRochesterMNUSA

9. Departments of Neurology and Biomedical EngineeringLayton Aging & Alzheimer's Disease Center, Oregon Center for Aging & Technology, Oregon Health & Science University and Portland Veteran's Affairs Medical CenterPortlandORUSA

10. Department of PathologyUniversity of WashingtonSeattleWAUSA

11. Center for Vital Longevity, University of Texas at DallasDallasTXUSA

12. Banner Alzheimer's InstitutePhoenixAZUSA

13. Austin Health, University of MelbourneMelbourneAustralia

14. Eli Lilly and CompanyIndianapolisINUSA

15. Cognitive Neuroscience DivisionTaub Institute, Columbia University College of Physicians and SurgeonsNew YorkNYUSA

16. Departments of Psychiatry, Neurology, and Epidemiology and BiostatisticsUniversity of California San Francisco, San Francisco VA Medical CenterSan FranciscoCAUSA

17. Alzheimer's AssociationChicagoILUSA

18. Division of NeuroscienceNational Institute on AgingBethesdaMDUSA

Funder

National Institute on Aging

Pfizer

Baxter International

Johnson and Johnson

Eli Lilly and Company

Bayer

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.03.003

Reference71 articles.

1. Early-Stage and Preclinical Alzheimer Disease

2. Revising the definition of Alzheimer's disease: a new lexicon

3. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by 5408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disintegration at the syntax-semantics interface in prodromal Alzheimer's disease: New evidence from complex sentence anaphora in amnestic Mild Cognitive Impairment (aMCI);Journal of Neurolinguistics;2024-05

2. Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial;Neurology Clinical Practice;2024-04

3. Current status of PET tracers for the early diagnosis of Alzheimer's disease;TrAC Trends in Analytical Chemistry;2024-03

4. Nanotechnology in the diagnostic and therapy for Alzheimer's disease;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-03

5. A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities;Frontiers in Pharmacology;2024-02-06